Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Evermil 5mg Tablets | 100-Count | EVEROLIMUS
Pharma

Evermil 5mg Tablets | 100-Count | EVEROLIMUS

$720

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse EVEROLIMUS — 5mg per tablet, 100-count pack. mTOR inhibitor for advanced renal cell carcinoma, neuroendocrine tumors, breast cancer (with exemestane), tuberous sclerosis complex, and organ transplant rejection. Key warning: Pneumonitis — monitor respiratory symptoms (can be asymptomatic early). Stomatitis management with specific rinses (not chlorhexidine). Hold before surgery. Avoid live vaccines. CYP3A4/P-gp substrate.

SKU
VES-008526-EVERMIL-5MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Evermil 5mg (EVEROLIMUS)?

mTOR inhibitor for advanced renal cell carcinoma, neuroendocrine tumors, breast cancer (with exemestane), tuberous sclerosis complex, and organ transplant rejection.

How it Works

Binds FKBP12, inhibiting mTORC1 — reduces tumor cell proliferation, survival, and angiogenesis. Same target as sirolimus but different pharmacokinetic profile.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
EVEROLIMUS
Dose per Tablet
5MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Stomatitis (mouth sores — very common), pneumonitis, fatigue, infection, hyperglycemia, hyperlipidemia, myelosuppression, impaired wound healing.

Safety Warnings

Pneumonitis — monitor respiratory symptoms (can be asymptomatic early). Stomatitis management with specific rinses (not chlorhexidine). Hold before surgery. Avoid live vaccines. CYP3A4/P-gp substrate. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.